Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Income from Non-Controlling Interests: 2015-2025

Historic Income from Non-Controlling Interests for Fortress Biotech (FBIO) over the last 11 years, with Sep 2025 value amounting to -$3.0 million.

  • Fortress Biotech's Income from Non-Controlling Interests rose 78.47% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.7 million, marking a year-over-year decrease of 122.03%. This contributed to the annual value of $74.9 million for FY2024, which is 19.95% down from last year.
  • As of Q3 2025, Fortress Biotech's Income from Non-Controlling Interests stood at -$3.0 million, which was up 89.03% from -$27.1 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Income from Non-Controlling Interests ranged from a high of $167.3 million in Q4 2023 and a low of -$224.2 million during Q4 2022.
  • Over the past 3 years, Fortress Biotech's median Income from Non-Controlling Interests value was -$13.8 million (recorded in 2024), while the average stood at $7.3 million.
  • Examining YoY changes over the last 5 years, Fortress Biotech's Income from Non-Controlling Interests showed a top increase of 247.41% in 2021 and a maximum decrease of 267.11% in 2021.
  • Fortress Biotech's Income from Non-Controlling Interests (Quarterly) stood at -$163.3 million in 2021, then plummeted by 37.28% to -$224.2 million in 2022, then soared by 174.64% to $167.3 million in 2023, then crashed by 88.32% to $19.6 million in 2024, then spiked by 78.47% to -$3.0 million in 2025.
  • Its last three reported values are -$3.0 million in Q3 2025, -$27.1 million for Q2 2025, and -$14.1 million during Q1 2025.